We, at Bioneb, have over the past five years developed leading ultrasonic vibrating platinum mesh technology for the nebulization and delivery of drugs in the most efficient and cost-effective manner. This is through the pulmonary tract, which is the most efficient way to deliver drugs.
Our technology produces nanoparticles of medication that are less than five microns in size, critical for successful pulmonary delivery. Human testing of many FDA approved drugs is ongoing.
Many companies and universities are racing against time to develop a successful vaccine for Covid-19. Unfortunately, a successful cure may be many months away.
Bioneb now are focusing all our efforts on preventative medication using various traditional medicines that have proven results for fighting viruses and bacteria.
Creating various formulations, nebulizing and Inhaling these medications, particles are deposited in the mouth, gums, throat, and lungs, exactly where the Corrona virus if found.
Current research and results are proving very positive in suppressing symptoms of Covid-19.
We do not have or claim to have a cure.
For more information, please visit www.bioneb.com
Company Details
- Employees
- 1
- Founded
- -
- Address
- 78 St Johns Street London, London,london Ec4m 7aa,united Kingdom
- Industry
- Mental Health Care
- NAICS
-
Offices of Mental Health Practitioners (except Physicians)
- Website
- http://www.bioneb.com
- Keywords
- medical, drug delivery, technology, healthcare.
- HQ
- London,, London
Bioneb Limited Questions
Bioneb Limited's website is http://www.bioneb.com
Bioneb Limited's LinkedIn profile is https://uk.linkedin.com/company/bioneb
Bioneb Limited has
1 employees.
View email and phone details for 1
employees at Bioneb Limited.
Bioneb Limited's industry is
Mental Health Care
Bioneb Limited's top competitors are
Galderma,
Gilead Sciences,
Desktop Genetics,
Eliquent Life Sciences,
Prokarium,
Lifebit,
Liquidia Corporation,
Optimhal-Protecsom.
Bioneb Limited's categories are Mental Health Care
Bioneb Limited's founding year is 2013
